TKK Symphony (TKKS) Extends Tender Offer For Seventh Time
by Kristi Marvin on 2020-02-12 at 7:51pm

TKK Symphony Acquisition Corporation (TKKS) announced this evening that it would be extending the expiration of its tender offer to purchase up to 25,000,000 shares at a purchase price of $10.28 (plus accrued interest) for a SEVENTH time.  The tender offer will now expire at 5:00 p.m. New York City time, tomorrow, Thursday, February 13, 2020, unless further extended or earlier terminated.

At this point, anything is possible. TKKS could extend every day up until February 20th.  We have no idea. HOWEVER, we have a twist…

That’s because TKKS also stated that, “If the parties are unable to close the transaction on or prior to February 20, 2020, TKK intends to issue a dividend of one warrant to purchase one-half of one ordinary share for each public ordinary share of TKK issued and outstanding as of February 21, 2020, for a total of 25,000,000 warrants to purchase an aggregate of 12,500,000 ordinary shares of TKK. Each such warrant will be identical to the warrants included in the units sold in the Company’s initial public offering. TKK will not issue such dividend if the parties close the transaction on or prior to February 20, 2020.

Not gonna lie….I don’t get it. This deal is set to expire on February 20th, so frankly, does a warrant dividend even matter if the company has to liquidate?  This press release leaves more questions than answers. I’m going to try and figure this one out, but right now, if the company can’t close by February 20th, it should liquidate. So what’s the point of issuing a warrant for half a share to a liquidating company? Unless they mean the vote happens prior to the 20th, but the closing happens after the 20th. However this seems like a poor way to motivate investors to close earlier.  If anything, it means they should drag their feet and make sure it happens as late as possible. Clearly I’m missing something, but stay tuned. Working to figure this one out…..

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved